MNPR - Monopar Therapeutics
57.61
1.810 3.142%
Share volume: 169,583
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$55.80
1.81
0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-09-2024 | 11-08-2024 | 05-13-2025 | 11-13-2025 | |
| Assets | ||||||
| Total Assets | 8.912 M | 7.180 M | 6.070 M | 55.085 M | 144.197 M | |
| Current Assets | 8.912 M | 7.180 M | 6.070 M | 55.076 M | 144.091 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 118.987 K | 61.017 K | 49.570 K | 523.556 K | 414.825 K | |
| Short Term Investments | 985.730 K | 998.840 K | 0.000 | 14.841 M | 15.998 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 7.808 M | 6.120 M | 6.020 M | 39.711 M | 127.677 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Assets | 0.000 | 0.000 | 0.000 | 9.102 K | 106.666 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||
| Total Liabilities and shareholders’ equity | 8.912 M | 7.180 M | 6.070 M | 55.085 M | 144.197 M | |
| Total liabilities | 1.435 M | 1.089 M | 1.123 M | 1.492 M | 2.639 M | |
| Total current liabilities | 1.435 M | 1.089 M | 1.123 M | 1.492 M | 2.569 M | |
| Accounts Payable | 1.435 M | 1.089 M | 1.123 M | 1.492 M | 2.569 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 70.881 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 70.881 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 7.477 M | 6.090 M | 4.947 M | 53.593 M | 141.558 M | |
| Common stock | 69.320 M | 69.645 M | 69.825 M | 132.033 M | 225.855 M | |
| Retained earnings | -61.847 M | -63.563 M | -64.867 M | -78.418 M | -84.309 M |